Bringing innovative healthcare products to market requires more than strong technology. It requires a clear, coordinated strategy across regulatory, reimbursement, pricing, and commercialization.
tJûn17 Life Sciences Advisors supports medical device, IVD diagnostics, biotechnology, and specialty pharmaceutical organizations with regulatory strategy, market access, pricing, and commercialization planning.
We advise manufacturers, investors, and other stakeholders; prepare and support key regulatory submissions, including INDs, NDAs, FDA briefing packages, and global submission documents; and represent clients in interactions with agencies such as the FDA and EMA.
We also support payer dossiers, health technology assessments, and evidence strategies incorporating clinical, economic, and comparative-effectiveness data.